Show simple item record

Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational Modifications

dc.contributor.authorSelheim, Frodeen_US
dc.date.accessioned2020-04-27T11:13:29Z
dc.date.available2020-04-27T11:13:29Z
dc.date.issued2019
dc.PublishedSelheim F. Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational Modifications. Current Medicinal Chemistry. 2019;26(28):5242-5243eng
dc.identifier.issn1875-533X
dc.identifier.issn0929-8673
dc.identifier.urihttps://hdl.handle.net/1956/22011
dc.language.isoengeng
dc.publisherBentham Scienceeng
dc.titleTargeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational Modificationsen_US
dc.typeJournal article
dc.date.updated2020-01-29T13:43:10Z
dc.description.versionacceptedVersionen_US
dc.rights.holderCopyright 2019 Bentham Science
dc.identifier.doihttps://doi.org/10.2174/092986732628191025094205
dc.identifier.cristin1785354
dc.source.journalCurrent Medicinal Chemistry
dc.source.pagenumber5242-5243
dc.identifier.citationCurrent Medicinal Chemistry. 2019;26(28):5242-5243
dc.source.volume26
dc.source.issue28


Files in this item

Thumbnail
Name:
Targeted+and+Immune-Based+Ther ...
Size:
547.6Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record